Roche to pay $2.4bn for remainder of Foundation Medicine

20-06-2018

Roche to pay $2.4bn for remainder of Foundation Medicine

Natee Meepian / iStockphoto.com

Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts.


Roche, Foundation Medicine, mergers and acquisitions, M&A, genomic profiling, oncology, personalised medicine,

More on this story

Roche to make $1.9bn acquisition
19-02-2018

LSIPR